help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Brien, P. J.
Right arrow Articles by Christenson, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Brien, P. J.
Right arrow Articles by Christenson, L. K.
(American Journal of Pathology. 2003;163:1245-1254.)
© 2003 American Society for Investigative Pathology

Thrombin Receptors and Protease-Activated Receptor-2 in Human Placentation

Receptor Activation Mediates Extravillous Trophoblast Invasion in Vitro

Peter J. O’Brien*{dagger}, Hideki Koi*{ddagger}, Samuel Parry*{ddagger}, Lawrence F. Brass*{dagger}§, Jerome F. Strauss, III*{ddagger}, Li-Peng Wang*§, John E. Tomaszewski*§ and Lane K. Christenson*{ddagger}

From the Departments of Medicine,* Pharmacology,{dagger} Pathology and Laboratory Medicine,§ and the Center for Research on Reproduction and Women’s Health,{ddagger} University of Pennsylvania, Philadelphia, Pennsylvania

Proteolysis of the thrombin receptor, protease activated receptor-1 (PAR1), may enhance normal and pathological cellular invasion, and indirect evidence suggests that activation of PAR1 expressed by invasive extravillous trophoblasts (EVTs) influences human placentation. Here we describe PAR1, PAR2, and PAR3 protein distribution in the developing human placenta and implicate PAR1 and PAR2 activation in functions central to EVT invasion. PAR1, PAR2, and PAR3 are expressed in cultured 8- to 13-week-old EVTs, and in situ in 18- to 20-week-old placental syncytiotrophoblasts and invasive trophoblasts. Thrombin, but not the PAR2 agonist peptide SLIGKV, inhibited proliferation in cultured EVTs, although both agonists stimulated phosphoinositide hydrolysis and EVT invasion through Matrigel barriers. Thrombin-induced phosphoinositide hydrolysis was completely inhibited and the thrombin effect on proliferation was prevented when PAR1 cleavage was first blocked with specific monoclonal antibodies, indicating that PAR1 is the predominant thrombin receptor on EVTs. Together these results support a role for PAR1, and potentially PAR2 and PAR3 in the invasive phase of human placentation.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
T. Kotani, A. Iwase, K. Ino, S. Sumigama, E. Yamamoto, H. Hayakawa, T. Nagasaka, A. Itakura, S. Nomura, and F. Kikkawa
Activator Protein-2 Impairs the Invasion of a Human Extravillous Trophoblast Cell Line
Endocrinology, September 1, 2009; 150(9): 4376 - 4385.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet
Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts
Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Sood, S. Kalloway, A. E. Mast, C. J. Hillard, and H. Weiler
Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells
Blood, April 15, 2006; 107(8): 3173 - 3180.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.